نتائج البحث - "Sara C. Erridge"

1

Supplementary Data from Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, IDH-wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::109744a2c92862781132af0ecf222543
https://doi.org/10.1158/1078-0432.22487442

2

Data from Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, IDH-wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88b32e4e9c69dd0eaf37cef44fe94660
https://doi.org/10.1158/1078-0432.c.6532518

3

Supplementary Figure from Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, IDH-wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21d66230eb0256698fea2e10f6ea94c9
https://doi.org/10.1158/1078-0432.22487427.v1

4

Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, IDH-wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial

المساهمون: Internal medicine, CCA - Cancer Treatment and quality of life, Pathology, Neurology, Cell biology, UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - (SLuc) Centre du cancer, UCL - (SLuc) Unité d'oncologie médicale, Institut de neurophysiopathologie (INP), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Neuro-Oncologie [Hôpital de la Timone - APHM], Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy

المصدر: Clinical Cancer Research, 28(12), 2527-2535. American Association for Cancer Research Inc.
Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 28, no.12, p. 2527-2535 (2022)
Clin Cancer Res
Tesileanu, C M S, Sanson, M, Wick, W, Brandes, A A, Clement, P M, Erridge, S C, Vogelbaum, M A, Nowak, A K, Baurain, J-F, Mason, W P, Wheeler, H, Chinot, O L, Gill, S, Griffin, M, Rogers, L, Taal, W, Rudà, R, Weller, M, McBain, C, van Linde, M E, Aldape, K, Jenkins, R B, Kros, J M, Wesseling, P, von Deimling, A, Hoogstrate, Y, de Heer, I, Atmodimedjo, P N, Dubbink, H J, Brouwer, R W W, van IJcken, W F J, Cheung, K J, Golfinopoulos, V, Baumert, B G, Gorlia, T, French, P J & van den Bent, M J 2022, ' Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, IDH-wildtype : Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial ', Clinical Cancer Research, vol. 28, no. 12, pp. 2527-2535 . https://doi.org/10.1158/1078-0432.CCR-21-4283
Clinical Cancer Research
Clinical Cancer Research, 2022, 28 (12), pp.2527-2535. ⟨10.1158/1078-0432.CCR-21-4283⟩